Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: Comparison between the acute state and after remission

European Archives of Psychiatry and Clinical Neuroscience

Volumn 247, Issue 4, 1997, Pages 228-233

  Frommberger, Ulrich H ^a   Bauer, Joachim ^a   Haselbauer, Peter ^a   Fräulin, Andrea ^a   Riemann, Dieter ^a   Berger, Mathias ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Depression; Schizophrenia; Stress interleukin 6, psychoimmunology

Indexed keywords

CYTOKINE; INTERLEUKIN 6;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERVIEW; MALE; MENTAL STRESS; PRIORITY JOURNAL; RATING SCALE; REMISSION; SCHIZOPHRENIA; TIME;

EID: 0030880358     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02900219     Document Type: Article

References (34)

1. Aarden LA, de Groot ER, Schaap OL, Lansdorp PM (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411-1416
2. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R), 3rd edn, revised. American Psychiatric Press, Washington DC
3. Barak V, Barak Y, Levine J, Nisman B, Roisman I (1995) Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. J Basic Clin Physiol Pharmacol 6:61-69
4. Bauer J, Ganter U, Strauss S, Stadtmüller G, Frommberger U, Bauer H, Volk B, Berger M (1992) The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. Res Immunol 143:650-656
5. Bauer J, Hohagen F, Ebert T, Timmer J, Ganter U, Krieger S, Lis S, Postier E, Voderholzer U, Berger M (1994) Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle. Clin Investig 72:315
6. Black PH (1994) Central nervous system-immune system interactions: psychoneuroendocrinology of stress and its immune consequences. Antimicrob Agents Chemother 38:1-6
7. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 90:10061-10065
8. De Rijk RH, Boelen A, Tilders FJH, Berkenbosch F (1994) Induction of plasma interleukin-6 by circulating adrenaline in the rat. Psychoneuroendocrinology 19:155-163
9. Ganguli R, Yang Z, Shurin G, Chengappa KNR, Brar JS, Gubbi AV, Rabin BS (1994) Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 51:1-10
10. Hornig-Rohan M, van Bell CT, Kuhn P, Amsterdam JD (1995) Acute phase proteins in affective illness. Biol Psychiatry 37: 607 (Abstract)
11. Joyce P, Hawes C, Mulder R, Sellman J, Wilson D, Boswell D (1992) Elevated levels of acute phase plasma proteins in major depression. Biol Psychiatry 32:1035-1041
12. Katila H, Appelberg B, Hurme M, Rimon R (1994) Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr Res 12:29-34
13. Kushner I (1991) The acute phase response: from Hippocrates to cytokine biology. Eur Cytokine Netw 2:75-80
14. LeMay LG, Vander AJ, Kluger MJ (1991) The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav 47:957-961
15. Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P (1993) Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 49:11-27
16. Maes M, Meltzer HY, Bosmans E (1994a) Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1β and IL-6 concentrations. Neuropsychobiology 30:57-60
17. Maes M, Meltzer HY, Stevens W, Cosyns P, Blockx (1994b) Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic-pituitary-adrenal axis in depression. Psychol Med 24:167-177
18. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer H (1995a) Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res 29: 141-152
19. Maes M, Meltzer H, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R (1995b) Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34:301-309
20. Maimone D, Cioni C, Rosa S, Macchia G, Aloisi F, Annunziata P (1993) Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1ß and TNFα. J Neuroimmunol 47:73-82
21. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389
22. Müller N (1997) Die Rolle des Zytokinnetzwerks im ZNS und psychische Störungen. Nervenarzt 68:11-20
23. Norris GJ, Benveniste EN (1993) Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 45:137-146
24. Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812
25. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H (1995) Cytokine production and serum proteins in depression. Scand J Immunol 41:534-538
26. Shintani F, Kanba S, Maruo N, Nakaki T, Nibuya M, Suzuki E, Kinoshita N, Yagi G (1991) Serum interleukin-6 in schizophrenic patients. Life Sci 49:661-664
27. Sluzewska A, Rybakowski J, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K (1995) Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 762:474-476
28. Sluzewska A, Rybakowski J, Bosnians E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K (1996) Indicators of immune activation in major depression. Psychiatry Res 64:161-167
29. Song C, Dinan T, Leonhard B (1994) Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord 30:283-288
30. Spitzer RL, Williams JB, Gibbon M (1987) Structured clinical interview for DSM-III-R (SClD). Biometrics Research Department, New York State Psychiatric Institute, New York
31. Spivak B, Radwan M, Bartur P, Wester R, Weizman A (1995) Antinuclear autoantibodies in chronic schizophrenia. Acta Psychiatr Scand 92:266-269
32. Stein TP, Schluter MD (1994) Excretion of 1L-6 by astronauts during spaceflight. Am J Physiol 266:E448-E452
33. Xu HM, Wei J, Hemmings GP (1994) Changes of plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment for schizophrenia. Br J Psychiatry 164:251-253
34. Zhou D, Kusnecov AW, Shurin MR, Paoli M de, Rabin BS (1993) Exposure to physical and psychological Stressors elevates plasma interleukin-6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133:2523-2530